Meeder Asset Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,817
| Closed | -$9.12K | – | 898 |
|
|
2024
Q1 | $9.12K | Hold |
3,817
| – | – | ﹤0.01% | 565 |
|
|
2023
Q4 | $6.34K | Hold |
3,817
| – | – | ﹤0.01% | 428 |
|
|
2023
Q3 | $7.33K | Hold |
3,817
| – | – | ﹤0.01% | 439 |
|
|
2023
Q2 | $5.5K | Hold |
3,817
| – | – | ﹤0.01% | 463 |
|
|
2023
Q1 | $8.02K | Hold |
3,817
| – | – | ﹤0.01% | 515 |
|
|
2022
Q4 | $4.31K | Sell |
3,817
-1,818
| -32% | -$2.05K | ﹤0.01% | 706 |
|
|
2022
Q3 | $9K | Sell |
5,635
-322
| -5% | -$514 | ﹤0.01% | 1357 |
|
|
2022
Q2 | $7K | Sell |
5,957
-2,037
| -25% | -$2.39K | ﹤0.01% | 1502 |
|
|
2022
Q1 | $13K | Buy |
+7,994
| New | +$13K | ﹤0.01% | 1446 |
|
|
2021
Q4 | – | Sell |
-7,783
| Closed | -$30K | – | 1614 |
|
|
2021
Q3 | $30K | Buy |
7,783
+2,866
| +58% | +$11K | ﹤0.01% | 1273 |
|
|
2021
Q2 | $16K | Buy |
+4,917
| New | +$16K | ﹤0.01% | 1527 |
|
|
2020
Q2 | – | Sell |
-186
| Closed | – | – | 2191 |
|
|
2020
Q1 | $0 | Buy |
+186
| New | – | ﹤0.01% | 2390 |
|
|
2019
Q4 | – | Sell |
-19
| Closed | – | – | 2319 |
|
|
2019
Q3 | $0 | Buy |
+19
| New | – | ﹤0.01% | 2186 |
|